The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Omega Healthcare Investors Inc

NYSE: OHI
Last

(U.S.) $36.12

Today's change-0.27 -0.74%
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.
 

Omega Healthcare Investors Inc

NYSE: OHI
Last

(U.S.) $36.12

Today's change-0.27 -0.74%
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.

Omega Healthcare Investors Inc crosses below 20-day moving average

Omega Healthcare Investors Inc closed lower Friday, dropping (U.S.)$0.27 or 0.74% to (U.S.)$36.12 and crossing below its 20-day moving average. Over the last five days, shares are unchanged, but are currently 3.63% below its 52-week high. This security has underperformed the S&P 500 by 4.44% during the last year.

Key company metrics

  • Open(U.S.) $36.50
  • Previous close(U.S.) $36.39
  • High(U.S.) $36.83
  • Low(U.S.) $35.72
  • Bid / Ask-- / --
  • YTD % change+3.26%
  • Volume1,987,733
  • Average volume (10-day)1,585,626
  • Average volume (1-month)2,034,484
  • Average volume (3-month)1,798,596
  • 52-week range(U.S.) $26.96 to (U.S.) $37.48
  • Beta0.71
  • Trailing P/E23.51×
  • P/E 1 year forward19.42×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.40
  • Dividend yield6.64%
  • Trailing EPS(U.S.) $1.54
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+37.25%

Based on its net profit margin of 37.25%, Omega Healthcare Investors Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.06%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue229213211202
Total other revenue--------
Total revenue229213211202
Gross profit--------
Total cost of revenue--------
Total operating expense871168676
Selling / general / administrative11162010
Research & development--------
Depreciation / amortization66626160
Interest expense (income), net operating--------
Unusual expense (income)103855
Other operating expenses, total--------
Operating income14297125126
Interest income (expense), net non-operating-42-39-41-40
Gain (loss) on sale of assets1320-2
Other--------
Income before tax114586484
Income after tax113586483
Income tax, total0000
Net income108566179
Total adjustments to net income--------
Net income before extra. items108566179
Minority interest-5-3-3-4
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items108566179
Inc. avail. to common incl. extra. items108566179
Diluted net income108566179
Dilution adjustment------0
Diluted weighted average shares199198198195
Diluted EPS excluding extraordinary itemsvalue per share0.540.280.310.41
Dividends per sharevalue per share0.580.570.560.55
Diluted normalized EPSvalue per share0.530.460.330.45